Roche Holding AG
RO.SWDividend Aristocrat • 37yrsAutomated dividend-safety read-out from payout, leverage, yield, profitability and track record. See the Financials tab for the full per-statement Financial Investigation. Educational only — not investment advice.
At a glance
Roche Holding AG (RO.SW) operates in the Drug Manufacturers - General industry and is based in Switzerland. It pays a quarterly dividend of CHF 9.80 a year, a yield of 2.47% at the current price of CHF 397.40. Roche Holding has raised its dividend for 37 consecutive years, which makes it a Dividend Aristocrat. Over the last five years the dividend has grown by an average of 1.5% a year. It paid out 64% of its earnings as dividends. 3 analysts cover it; their average 12-month price target of CHF 448.00 is 12.7% above the current price.
Written automatically from the figures on this page, as of Oct 24, 2026. Facts only, not a recommendation.
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagnostic instruments; and digital health solutions.
Business description sourced from Yahoo Finance / company filings. Not affiliated with SimplyWallStreet.
Key Metrics
Valuation
Profitability
Financial Health
Data provided by Yahoo Finance via yfinance. Updated daily. Not investment advice.